Daniel R. Zwahlen
Papers
1
Total Citations
3
H-Index
1
About
Dr. Daniel R. Zwahlen is a leading radiation oncologist whose research focuses on optimizing stereotactic body radiotherapy (SBRT) for prostate cancer, particularly through fractionation schedule comparisons. His most impactful work, a 2023 propensity score matched pair analysis, directly compared five-fraction versus seven-fraction SBRT regimens in intermediate- and high-risk prostate cancer patients. This study, which has garnered early attention with 3 citations, provides critical evidence on balancing treatment efficacy with toxicity profiles, helping to refine clinical protocols for non-invasive cancer management. Dr. Zwahlen’s contributions are central to advancing personalized radiotherapy, reducing treatment burden while maintaining tumor control. His research addresses a key question in modern oncology: how to shorten radiation courses without compromising safety or outcomes. By leveraging retrospective data from multiple institutions, he bridges the gap between clinical practice and evidence-based guidelines. Dr. Zwahlen’s work is essential reading for clinicians and researchers exploring dose escalation, hypofractionation, and the evolving landscape of prostate cancer radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1